# Chipmos Technologies Inc: financial statements, quarterly

IMOS · Nasdaq · CIK 1123134 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/imos.md) · [Financials](/companies/imos/financials.md) · [Filings](/companies/imos/filings.md) · [Insiders](/companies/imos/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/imos/financials.md?period=annual).

## Balance sheet

| Line item | Unit | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [271](/filings/0001193125-18-121873.md) | [152](/filings/0001193125-19-117833.md) | [157](/filings/0001193125-20-115821.md) | [146](/filings/0001193125-21-121875.md) | [213](/filings/0001193125-22-104872.md) | [322](/filings/0000950170-23-012607.md) | [403](/filings/0000950170-24-043516.md) | [464](/filings/0000950170-25-053927.md) |
| Current assets | $m | [479](/filings/0001193125-18-121873.md) | [388](/filings/0001193125-19-117833.md) | [393](/filings/0001193125-20-115821.md) | [440](/filings/0001193125-21-121875.md) | [594](/filings/0001193125-22-104872.md) | [597](/filings/0000950170-23-012607.md) | [822](/filings/0000950170-24-043516.md) | [721](/filings/0000950170-25-053927.md) |
| Total assets | $m | [1,122](/filings/0001193125-18-121873.md) | [1,082](/filings/0001193125-19-117833.md) | [1,147](/filings/0001193125-20-115821.md) | [1,249](/filings/0001193125-21-121875.md) | [1,533](/filings/0001193125-22-104872.md) | [1,463](/filings/0000950170-23-012607.md) | [1,508](/filings/0000950170-24-043516.md) | [1,384](/filings/0000950170-25-053927.md) |
| Current liabilities | $m | [234](/filings/0001193125-18-121873.md) | [171](/filings/0001193125-19-117833.md) | [168](/filings/0001193125-20-115821.md) | [204](/filings/0001193125-21-121875.md) | [267](/filings/0001193125-22-104872.md) | [211](/filings/0000950170-23-012607.md) | [243](/filings/0000950170-24-043516.md) | [267](/filings/0000950170-25-053927.md) |
| Total liabilities | $m | [511](/filings/0001193125-18-121873.md) | [494](/filings/0001193125-19-117833.md) | [494](/filings/0001193125-20-115821.md) | [512](/filings/0001193125-21-121875.md) | [663](/filings/0001193125-22-104872.md) | [661](/filings/0000950170-23-012607.md) | [699](/filings/0000950170-24-043516.md) | [621](/filings/0000950170-25-053927.md) |
| Shareholders' equity | $m | [611](/filings/0001193125-18-121873.md) | [589](/filings/0001193125-19-117833.md) | [653](/filings/0001193125-20-115821.md) | [738](/filings/0001193125-21-121875.md) | [870](/filings/0001193125-22-104872.md) | [802](/filings/0000950170-23-012607.md) | [809](/filings/0000950170-24-043516.md) | [763](/filings/0000950170-25-053927.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 699,983,126 at 2025-12-31, from the cover of the [20-F filed 2026-04-14](/filings/0001193125-26-153743.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.